Skip to content
BidBenchmark

Contract award

ARISAN THERAPEUTICS INC

TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.
PIID
75N93026C00012
Award key
CONT_AWD_75N93026C00012_7529_-NONE-_-NONE-
Recipient UEI
PYRKTQPNVJZ8
Source as of
Current award value
$2,933,5473
Obligated to date
$2,933,5472
Potential with options
$23,878,9873
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Carlsbad, California
Set-aside
No set-aside used
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition20 offers received
Period of performance
Aug 3, 2026Jun 30, 2027Through Jun 30, 2027 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Jul 29, 2026Initial award$2,933,547.00$2,933,547.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2fda73ee9c259
contractor_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2fda73ee9c259
current_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2fda73ee9c259
naics_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2fda73ee9c259
potential_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2fda73ee9c259
psc_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2fda73ee9c259
total_obligatedUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2fda73ee9c259

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 1 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75N93026C00012 — ARISAN THERAPEUTICS INC · BidBenchmark